Preparation and solid-state characterization of three novel multicomponent solid forms of oxcarbazepine: Improvement in solubility through saccharin cocrystal

Crystal Growth and Design

Volumn 12, Issue 8, 2012, Pages 4211-4224

  Chadha, Renu ^a   Saini, Anupam ^a   Jain, Dharamvir S ^b   Venugopalan, P ^b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC AQUEOUS MEDIUM; ANTIEPILEPTIC DRUGS; AQUEOUS CONDITION; AQUEOUS SOLUBILITY; CO-CRYSTALS; DESOLVATION; HOT-STAGE MICROSCOPY; IN-VIVO; MULTICOMPONENTS; OXCARBAZEPINE; PHYSICAL STABILITY; POWDER XRD; RATE-LIMITING STEPS; SINGLE CRYSTAL X-RAY ANALYSIS; SINGLE CRYSTAL X-RAY DIFFRACTION; SOLID FORMS; SOLID STATE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLUTION METHODS; STRUCTURAL CHANGE; SUCCINIC ACIDS; UNIT CELLS;

ACETIC ACID; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULES; SOLUBILITY; SUGAR SUBSTITUTES; SUGARS; THERMOGRAVIMETRIC ANALYSIS; X RAY DIFFRACTION;

SINGLE CRYSTALS;

EID: 84864766981     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg3007102     Document Type: Article

References (65)

1. Trask, A. V. Mol. Pharm. 2007, 4, 301-309
2. Regulatory Classification of Pharmaceutical Co-Crystals; U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER): Silver Spring, MD, 2011.
3. Schultheiss, N.; Newman, A. Cryst. Growth Des. 2009, 9, 2950-2967
4. Chadha, R.; Saini, A.; Arora, P.; Jain, D. V. S.; Dasgupta, A.; Guru Row, T. N. CrystEngComm 2011, 13, 6271-6284
5. Morissette, S. L.; Almarsson, O.; Peterson, M. L.; Remenar, J. F.; Read, M. J.; Lemmo, A. V.; Ellis, S.; Cima, M. J.; Gardner, C. R. Adv. Drug Delivery Rev. 2004, 56, 275-300
6. Vippagunta, S. R.; Brittain, H. G.; Grant, D. J. W. Adv. Drug Delivery Rev. 2001, 48, 3-26
7. Chadha, R.; Arora, P.; Kaur, R.; Saini, A.; Singla, M. L.; Jain, D. V. S. Acta Pharm. 2009, 59, 245-257
8. Chadha, R.; Arora, P.; Saini, A.; Jain, D. V. S. AAPS PharmSciTech 1995, 11, 1328-1339
9. Khankari, R. K.; Grant, D. J. W. Thermochim. Acta 1995, 248, 61-79
10. Pudipeddi, M.; Serajuddin, A. T. M.; Grant, D. J. W.; Stahl, P. H. Solubility and dissolution of weak acids, bases and salts. In Handbook of Pharmaceutical Salts: Properties, Selection and Use, 1 st ed.; Stahl, P. H.; Wermuth, C. G., Eds.; Wiley-VCH: Weinheim, 2002; pp 19-40.
11. Hancock, B. C.; Parks, M. Pharm. Res. 2000, 17, 397-404
12. Berge, S. M.; Bighley, L. D.; Monkhouse, D. C. J. Pharm. Sci. 1977, 66, 1-19
13. Paulekuhm, G. S.; Dressman, J. B.; Saal, C. J. Med. Chem. 2007, 50, 6665-6672
14. Smith, A. J.; Kavuru, P.; Wojtas, L.; Zaworotko, M. J.; Shytle, R. D. Mol. Pharmaceutics 2011, 8, 1867-1876
15. Sanphui, P.; Goud, N. R.; Khandavilli, U. B. R.; Nangia, A. Cryst. Growth Des. 2011, 11, 4135-4145
16. Shiraki, K.; Takata, N.; Takano, R.; Hayashi, Y.; Terada, K. Pharm. Res. 2008, 25, 2581-2592
17. Chadha, R.; Saini, A.; Arora, P.; Bhandari, S. Crit. Rev. Ther. Drug Carrier Syst. 2012, 29, 183-218
18. Stanton, M. K.; Bak, A. Cryst. Growth Des. 2008, 8, 3856-3862
19. Shan, N.; Zaworotko, M. Polymorphic crystal forms and cocrystals in drug delivery (crystal engineering). In Burger's Medicinal Chemistry and Drug Discovery; John Wiley & Sons: New York, 2010; DOI: 10.1002/0471266949. bmc156; pp 187-218.
20. McNamara, D. P.; Childs, S. L.; Giordano, J.; Iarriccio, A.; Cassidy, J.; Shet, M. S.; Mannion, R.; O'Donnell, E.; Park, A. Pharm. Res. 2006, 23, 1888-1897
21. Cheney, M. L.; Shan, N.; Healey, E. R.; Hanna, M.; Wojtas, L.; Zaworotko, M. J.; Sava, V.; Song, S.; Sanchez-Ramos, J. R. Cryst. Growth Des. 2010, 10, 394-405
22. Hickey, M. B.; Peterson, M. L.; Scoppettuolo, L. A.; Morrisette, S. L.; Vetter, A.; Guzman, H.; Remenar, J. F.; Zhang, Z.; Tawa, M. D.; Haley, S.; Zaworotko, M. J.; Almarsson, O. Eur. J. Pharm. Biopharm. 2007, 67, 112-119
23. Cheney, M. L.; Weyna, D. R.; Shan, N.; Hanna, M.; Wojtas, L.; Zaworotko, M. J. J. Pharm. Sci. 2011, 100, 2172-2181
24. Sheikh, A. Y.; Abd Rahim, S.; Hammond, R. B.; Roberts, K. J. CrystEngComm 2009, 11, 501-509
25. Childs, S. L.; Hardcastle, K. I. Cryst. Growth Des. 2007, 7, 1291-1304
26. Childs, S. L.; Chyall, L. J.; Dunlap, J. T.; Smolenskaya, V. N.; Stahly, B. C.; Stahly, G. P. J. Am. Chem. Soc. 2004, 127, 13335-13342
27. Rodríguez-Hornedo, N.; Nehm, S. J.; Seefeldt, K. F.; Pagán-Torres, Y.; Falkiewicz, C. J. Mol. Pharmaceutics 2006, 3, 362-367
28. Stanton, M. K.; Kelly, R. C.; Colletti, A.; Langley, M.; Munson, E. J.; Peterson, M. L.; Roberts, J.; Wells, M. J. Pharm. Sci. 2011, 100, 2734-2743
29. Rager, T.; Hilfiker, R. Cryst. Growth Des. 2010, 10, 3237-3241
30. Zhang, G. G.; Henry, R. F.; Borchardt, T. B.; Lou, X. J. Pharm. Sci. 2007, 96, 990-995
31. Florence, A. J.; Johnston, A.; Price, S. L.; Nowell, H.; Kennedy, A. R.; Shankland, N. J. Pharm. Sci. 2006, 95, 1918-1930
32. Harris, R. K.; Ghi, R. Y.; Puschmann, H.; Apperley, D. C.; Griesser, U. J.; Hammond, R. B.; Ma, C.; Roberts, K. J.; Pearce, G. J.; Yates, J. R.; Pickard, C. J. Org. Process Res. Dev. 2005, 9, 902-910
33. Childs, S. L.; Rodriguez-Hornedo, N.; Reddy, L. S.; Jayasankar, A.; Maheshwari, C.; McCausland, L.; Shipplett, R.; Stahly, B. C. CrystEngComm 2008, 10, 856-864
34. Fleischman, S. G.; Kuduva, S. S.; McMahon, J. A.; Moulton, B.; Walsh, R. D. B.; Rodriguez-Hornedo, N.; Zaworotko, M. J. Cryst. Growth Des. 2003, 3, 909-919
35. Jayasankar, A.; Somwangthanaroj, A.; Shao, Z. J.; Rodriguez-Hornedo, N. Pharm. Res. 2006, 23, 2381-2392
36. Seefeldt, K.; Miller, J.; Alvarez-Nunez, F.; Rodriguez-Hornedo, N. J. Pharm. Sci. 2007, 96, 1147-1158
37. Porter, W. W., III; Elie, S. C.; Matzger, A. J. Cryst. Growth Des. 2008, 8, 14-16
38. Ter Horst, J. H.; Deij, M. A.; Cains, P. W. Cryst. Growth Des. 2009, 9, 1531-1537
39. Rabasseda, X. Drugs Today 2001, 37, 333-355
40. Bialer, M. Oxcarbazepine. In Anti-Epileptic Drugs; Levy, R. H.; Mattson, R. H.; Meldrum, B. S.; Perucca, E., Eds.; Lippincott Williams & Wilkins: Philadelphia, 2002; Chemistry, biotransformation and pharmacokinetics, pp 459-465.
41. Amidon, G. L.; Lunnernas, H.; Shah, V. P.; Crison, J. R. Pharm. Res. 1995, 12, 413-420
42. Stahl, P. H. Novartis-Pharmaceutische Entwicklung 1972, not supplied.
43. Myllnen, P. Search of Models for Hepatic and Placental Pharmacokinetics, Dissertation, Department of Pharmacology and Toxicology, University of Oulu, Finland, 2003.
44. Patel, N.; Chotai, N.; Patel, J.; Soni, T.; Desai, J.; Patel, R. Dissolution Technol. 2008, 28-33
45. Kalia, A.; Khurana, S.; Bedi, N. Int. J. Pharm. Pharm. Sci. 2009, 1, 12-23
46. Douroumis, D.; Fahr, A. Colloids Surfaces B: Biointerfaces 2007, 59, 208-214
47. Bhatt, P. P.; Kidane, A.; Edwards, K. U.S. Patent 7722898 B2, 2010.
48. Douroumis, D.; Bouropoulos, N.; Fahr, A. J. Pharm. Pharmacol. 2007, 59, 645-653
49. Aronhime, J.; Dolitzky, B.-H.; Berkovich, Y.; Garth, N. WO 02/064557A3, 2002.
50. Venkataraman, S.; Raju, N. S.; Purandhar, K.; Reddy, L. A.; Kondaiah, G. C. M. U.S. Patent 2006/0166968 A1, 2006.
51. Lutker, K. M.; Matzger, A. J. J. Pharm. Sci. 2010, 99, 794-803
52. Brzeczko, A. W.; Doney, J. A. WO 2008/092046 A2, 2008.
53. U.S. Food and Drug administration approved GRAS list. EAFUS: A Food Additive Database, http://www.cfsan.fda.gov/-dms/eafus.html.
54. Luszczki, J. J.; Borowicz, K. K.; Swiader, M.; Czuczwar, S. J. Epilepsia 2003, 44, 489-499
55. Sheldrick, G. M. SHELX-97, Program for the Solution and Refinement of Crystal Structures; University of Göttingen: Göttingen, Germany, 1997.
56. Litchfield, J. T.; Wilcoxon, F. J. Pharmacol. Exp. Ther. 1949, 96, 99-113
57. Bag, P. P.; Patni, M.; Reddy, C. M. CrystEngComm 2011, 13, 5650-5652
58. Lu, E.; Rodriguez-Hornedo, N.; Suryanarayanan, R. CrystEngComm 2008, 10, 665-668
59. Aakeröy, C. B.; Desper, J.; Salmon, D. J. Cryst. Growth Des. 2006, 6, 1033-1042
60. Hempel, A.; Camerman, N.; Mastropaolo, D. Acta Crystallogr. 2005, E61, o1313-o1315
61. Aakeröy, C. B.; Hussain, I.; Desper, J. Cryst. Growth Des. 2006, 6, 474-480
62. Childs, S. L.; Wood, P. A.; Rodríguez-Hornedo, N.; Reddy, L. S.; Hardcastle, K. I. Crystal Growth Des. 2009, 9, 1869-1888
63. Cabeja, A. J. C.; Day, G. M.; Motherwell, W. D. S.; Jones, W. Cryst. Growth Des. 2007, 7, 100-107
64. Nehm, S.; Rodríguez-Spong, B.; Rodríguez-Hornedo, N. Cryst. Growth Des. 2006, 6, 592-600
65. Maheshwari, C.; Jayasankar, A.; Khan, N. A.; Amidon, G. E.; Rodríguez-Hornedo, N. CrystEngComm 2009, 11, 493-500